Phosphatidylinositol cycle (PI cycle)

The **phosphatidylinositol cycle** is a central metabolic pathway in eukaryotic cells responsible for the synthesis and turnover of phosphatidylinositol (PI) and its phosphorylated derivatives, collectively known as polyphosphoinositides. This cycle plays a crucial role in cell signaling by generating key second messengers such as diacylglycerol (DAG) and inositol trisphosphate (IP₃), which mediate diverse cellular responses including calcium release from intracellular stores, activation of protein kinase C, regulation of membrane identity, cytoskeletal organization, ion transport at membrane contact sites between the endoplasmic reticulum and plasma membrane, and control over cell proliferation. The intermediates are regenerated through coordinated enzymatic reactions that require significant metabolic energy. Dysregulation or altered composition of lipids within this cycle is implicated in diseases such as cancer—where changes affect Akt activation—and genome instability due to defective DNA damage response pathways. While drugs like wortmannin target enzymes within this pathway for research purposes or potential therapeutic intervention, the "phosphatidylinositol cycle" itself refers to a biochemical process rather than a single molecular target such as an enzyme or receptor; thus it is not considered a direct therapeutic target but rather encompasses several druggable nodes within its network.

Other names

PI-cyclePhosphoinositide cyclePtdIns cycle

Inhibition of PI kinases, affecting downstream lipid signaling and cell processes such as DNA replication, proteasome-mediated degradation, and chromatin remodeling